Your browser doesn't support javascript.
loading
Efomycine U, a new C2-asymmetric elaiophylin derivative from Streptomyces malaysiensis DSM 4137.
Xu, Jing; Wu, Jingwan; Zhou, Dongdong; Zhang, Xuexia; Leadlay, Peter F.
Affiliation
  • Xu J; Collaborative Innovation Center of Ecological Civilization, School of Chemical Engineering and Technology, Hainan University, Haikou, China.
  • Wu J; Department of Biochemistry, University of Cambridge, Cambridge, UK.
  • Zhou D; Collaborative Innovation Center of Ecological Civilization, School of Chemical Engineering and Technology, Hainan University, Haikou, China.
  • Zhang X; Collaborative Innovation Center of Ecological Civilization, School of Chemical Engineering and Technology, Hainan University, Haikou, China.
  • Leadlay PF; Collaborative Innovation Center of Ecological Civilization, School of Chemical Engineering and Technology, Hainan University, Haikou, China.
Nat Prod Res ; : 1-6, 2023 Jun 02.
Article in En | MEDLINE | ID: mdl-37265103
ABSTRACT
Chemical examination of an actinomycete strain Streptomyces malaysiensis DSM 4137 derived from a soil sample derived isolate Streptomyces sp. DSM 3816, yielded a new C2-asymmetric elaiophylin derivative efomycine U (1) and a known analogue halichoblelide D (2). These structures were unambiguously elucidated on the basis of extensive NMR spectroscopic and mass spectrometric analyses. All compounds isolated were subjected to antimicrobial, cytotoxic and immnosuppressive activities evaluation.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Prod Res Year: 2023 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Prod Res Year: 2023 Type: Article Affiliation country: China